###begin article-title 0
PIN1 gene variants in Alzheimer's disease
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 290 295 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
Peptidyl-prolyl isomerase, NIMA-interacting 1 (PIN1) plays a significant role in the brain and is implicated in numerous cellular processes related to Alzheimer's disease (AD) and other neurodegenerative conditions. There are confounding results concerning PIN1 activity in AD brains. Also PIN1 genetic variation was inconsistently associated with AD risk.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 123 131 <span type="species:ncbi:9606">patients</span>
We performed analysis of coding and promoter regions of PIN1 in early- and late-onset AD and frontotemporal dementia (FTD) patients in comparison with healthy controls.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
Analysis of eighteen PIN1 common polymorphisms and their haplotypes in EOAD, LOAD and FTD individuals in comparison with the control group did not reveal their contribution to disease risk.
###end p 6
###begin p 7
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 186 196 186 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In silico </italic>
###xml 438 443 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 29 37 <span type="species:ncbi:9606">patients</span>
###xml 140 148 <span type="species:ncbi:9606">patients</span>
###xml 384 391 <span type="species:ncbi:9606">patient</span>
In six unrelated familial AD patients four novel PIN1 sequence variants were detected. c.58+64C>T substitution that was identified in three patients, was located in an alternative exon. In silico analysis suggested that this variant highly increases a potential affinity for a splicing factor and introduces two intronic splicing enhancers. In the peripheral leukocytes of one living patient carrying the variant, a 2.82 fold decrease in PIN1 expression was observed.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
Our data does not support the role of PIN1 common polymorphisms as AD risk factor. However, we suggest that the identified rare sequence variants could be directly connected with AD pathology, influencing PIN1 splicing and/or expression.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 532 533 532 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 534 535 534 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
PIN1 is a ubiquitously expressed protein, belonging to the evolutionarily conserved peptidyl-prolyl isomerase (PPIase) family. PIN1 isomerizes p(Ser/Thr)-Pro motifs in the target proteins, which leads to the alteration of their structure, function, intracellular localization and/or stability [1]. Previous studies have demonstrated that PIN1 plays a crucial role in multiple cellular processes and, likewise, it has been implicated in pathogenesis of several diseases, including cancer, inflammation to neurodegenerative diseases [2-8].
###end p 11
###begin p 12
###xml 115 116 115 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 257 258 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 259 261 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 373 375 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 562 563 556 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 564 566 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 739 741 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 844 848 838 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis </italic>
###xml 932 933 923 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 934 936 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 937 939 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1034 1036 1025 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1095 1096 1086 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 1097 1099 1088 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1258 1260 1249 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 175 179 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1085 1093 <span type="species:ncbi:9606">patients</span>
###xml 1179 1187 <span type="species:ncbi:9606">patients</span>
The gene encoding PIN1 maps to chromosome 19p13.2, a region associated with late-onset Alzheimer's disease (LOAD) [9]. Moreover, PIN1 is the only known gene whose knockout in mice can cause both Tau and Abeta-related pathologies in an age-dependent manner [4,10]. It was shown that PIN1-catalysed conformation change of pT668 could prevent amyloidogenic processing of APP [10]. Additionally, in a similar manner PIN1 may indirectly reverse the hyperphosphorylation of Tau, restoring its ability to bind microtubules, as well as inhibit GSK3beta phosphorylation [5,11]. As overexpression of PIN1 in vitro induced a reduction in amyloidogenic processing of APP, it has been proposed that functional PIN1 could prevent or slow down AD onset [10]. On the other hand, PIN1 dysfunction or down-regulation e.g. under the oxidative stress, would favor cis form of pT668 APP and toxic Abeta production, leading finally to neurodegeneration [5,12,13]. However, there are confounding results considering the activity and the role of PIN1 in AD [14]. PIN1 protein was depleted in hippocampi of AD patients [2,15]. However, others showed that in the cortex of the frontal lobes of MCI and AD patients PIN1 levels and activity were increased compared to healthy controls [16].
###end p 12
###begin p 13
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 238 246 <span type="species:ncbi:9606">patients</span>
Recently, PIN1 expression has been shown to increase during neuronal differentiation, which led to suggestion that PIN1 dysfunction or downregulation could favor cell cycle re-entry [17-19]. This could result in aneuploidy observed in AD patients brains [20]. Indeed, several lines of evidence indicate that disturbed maintenance and segregation of chromosomes, DNA damage and impaired repair could contribute to AD [21-23].
###end p 13
###begin p 14
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 574 579 574 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 489 497 <span type="species:ncbi:9606">patients</span>
PIN1 downregulation or dysfunction could result not only from oxidative stress, but also could be connected with genetic variability [10,12,15,17,24]. Segat et al. demonstrated that the carriers of PIN1 -842C allele and/or -842C/-667C haplotype have an increased risk of AD, lower age of onset, and reduced PIN1 levels in peripheral mononuclear cells [12]. Moreover, individuals with amnestic MCI recruited from the same population showed a similar genotype distribution of -842 SNP as AD patients in Segat et al. (2007) study [12,25]. However, other studies on the role of PIN1 genetic variants in AD did not repeat the initial findings [26-28].
###end p 14
###begin p 15
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 172 177 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 378 379 378 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 468 473 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 555 560 555 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 592 600 <span type="species:ncbi:9606">patients</span>
To our knowledge, a thorough analysis of haplotypes that are formed by a set of PIN1 SNPs has not been described yet. Moreover, there were no studies on the involvement of PIN1 variants in early onset AD (EOAD), familial AD, and FTD, despite the fact that decreased PIN1 expression and depletion of neuronal nuclear PIN1 has been suggested to be a common feature in AD and FTD [7]. Given supporting evidence for PIN1 role in the brain, and yet unresolved influence of PIN1 sequence variation in AD and FTD, we decided to perform an exhaustive analysis of PIN1 in a group of Polish AD and FTD patients.
###end p 15
###begin title 16
Methods
###end title 16
###begin p 17
###xml 901 903 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 904 906 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 112 120 <span type="species:ncbi:9606">patients</span>
###xml 221 229 <span type="species:ncbi:9606">patients</span>
###xml 327 335 <span type="species:ncbi:9606">patients</span>
###xml 399 407 <span type="species:ncbi:9606">patients</span>
111 late onset (mean age of onset +/- SD: 73.2 +/- 5.0 years, range 66-88; 69.4% females) and 49 early onset AD patients (mean age of onset +/- SD: 52.6 +/- 9.8 years; 57.1% females), and 57 frontotemporal dementia (FTD) patients (mean age of onset: 59.3 +/- 12.3 years; 43.9% females) were recruited for the study. Twenty-six patients in the EOAD group have a family history of AD recorded, and 70 patients in the LOAD group claim a family history of dementia. The control group consisted of 104 healthy, non-demented individuals (mean age +/- SD: 75.1 +/- 5.2 years, range: 68-90; 71.15% females). AD diagnosis fulfilled the criteria of National Institute of Neurological and Communicative Disorders and Stroke - Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) for probable AD, whereas FTD was diagnosed according to Lund and Manchester Groups (1994) and Neary (1998) criteria [29,30]. The control subjects had normal mental status test scores and no clinical evidence of cognitive deficits in neurological examination.
###end p 17
###begin p 18
###xml 4 16 <span type="species:ncbi:9606">participants</span>
All participants or their relatives provided written, informed consent and the study was approved by the Ethics Committee of the MSWiA Hospital in Warsaw in accordance with the principles of the Helsinki Declaration.
###end p 18
###begin p 19
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 232 233 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
PIN1 promoter (1545 kb upstream the ATG translation initiation codon; NCBI GenBank ) and coding regions (4 exons with flanking intronic regions of about 100 nt; NCBI GenBank , ) were amplified (primers are listed in Additional file 1). Analyzed fragments covered 18 annotated DNA variations (rs7247933, rs4804459, rs2233678, rs35794537, rs2233679, rs2233680, rs7250788, rs35973416, rs28589723, rs2233681, rs2233682, rs2233683, rs2010457, rs11540415, rs34412035, rs11540414, rs3178950, rs35575918).
###end p 19
###begin p 20
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE </italic>
###xml 173 179 173 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE4 </italic>
###xml 187 192 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE4</italic>
###xml 199 205 199 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE4 </italic>
###xml 219 224 219 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE4</italic>
###xml 61 69 <span type="species:ncbi:9606">Patients</span>
APOE genotypes were determined as described previously [31]. Patients and controls were stratified into two subgroups, according to APOE status: those carrying at least one APOE4 allele (APOE4+) and APOE4 non-carriers (APOE4-).
###end p 20
###begin p 21
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 379 380 379 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S2">2</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
###xml 116 124 <span type="species:ncbi:9606">patients</span>
###xml 169 177 <span type="species:ncbi:9606">patients</span>
First, sequencing of PIN1 in DNA samples from EOAD and FTD patients was performed. Four identified variants in EOAD patients were screened in the control group and LOAD patients using denaturing high performance liquid chromatography (dHPLC). DHPLC analysis was performed as described previously (for DHPLC temperature for the analysis of PIN1 gene fragments see Additional file 2) [32,33]. Both groups were also screened for SNPs heterozygous in the Polish population (rs4804459, rs2233678, rs2233679, rs2233682, rs2233683, rs2010457).
###end p 21
###begin p 22
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 429 434 <span type="species:ncbi:9606">human</span>
The identified promoter DNA substitution was examined for introducing potential differences in transcription factor binding sites using MatInspector (Geneomatix software, Germany, [34]) and Mapper . The possible effect of identified DNA variants on splicing was investigated using ESEfinder (release 3.0) [35,36] and Automated Splice Site Analyses [37,38]. ESEfinder identifies putative exon splicing enhancers responsive to the human serine/arginine-rich (SR) proteins, whereas Automated Splice Site Analyses evaluates changes in splice site strength based on information theory based models. Analysis of intronic sequences containing mutations were done also with application of RegRNA: A Regulatory RNA Motifs and Elements Finder . ConSeq  program was used to evaluate the degree of conservation of mutated residue in the protein coding sequence.
###end p 22
###begin p 23
###xml 134 138 134 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174; </sup>
###xml 46 53 <span type="species:ncbi:9606">patient</span>
Total RNA was isolated from leukocytes of the patient with c.58+64C>T variant and four healthy individuals, using standard TRI Reagent(R) method, according to manufacturer's procedure (Ambion). The SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen) was used to synthesize first-strand cDNA, using oligo-dT primers and equal amount of RNA from the samples. Then all samples were adjusted to 20 ng/mul cDNA. qPCR was performed in triplicates in a 25 mul reaction mix with 3 mul of diluted cDNA template, using standard SYBR Green protocol on ABI 7500 Sequence Detection System (Applied Biosystems). The thermal cycling conditions comprised an initial denaturation step at 95degreesC, then 40 cycles of 95degreesC for 15 s and 60degreesC for 1 min. The temperature range used for the melting curve generation was from 60degreesC to 95degreesC. The dissociation plots indicated a single peak in all reactions.
###end p 23
###begin p 24
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 420 433 420 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-deltadeltaCt</sup>
###xml 471 476 471 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 483 490 <span type="species:ncbi:9606">patient</span>
The primer set for PIN1 was designed to span intron 3 in order to distinguish amplified cDNA from genomic DNA. No primer dimers were observed. The level of PIN1 mRNA was normalized to that of succinate dehydrogenase complex subunit A (SDHA). The relative quantification method was applied to analyze real-time PCR results. Similar efficiencies of target and reference genes allowed us to use the comparative Ct method (2-deltadeltaCt) to calculate relative expression of PIN1 in our patient in comparison with four healthy individuals.
###end p 24
###begin p 25
###xml 379 381 379 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
Comparisons of allele and genotype frequencies between the affected and the control group were carried out using the chi-square or Fisher exact (2-tailed) tests. The Hardy-Weinberg equilibrium was tested using a chi-square goodness-of-fit test. Kruskal-Wallis test was used to compare age at onset of LOAD symptoms between genotype groups. Statistical difference was accepted at p < 0.05.
###end p 25
###begin p 26
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
Haplotype assignment and linkage disequilibrium (LD) between each pair-wise combination of SNPs heterozygous in the studied groups as expressed by D' was calculated using the Haploview 4.0 (, [39]). Haplotypes were inferred using EM algorithm, which was implemented in Haploview [40].
###end p 26
###begin title 27
Results
###end title 27
###begin p 28
###xml 86 91 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 375 376 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
Genotyping promoter region and 4 exons with adjacent flanking intron sequences of the PIN1 gene revealed six heterozygous polymorphisms (rs4804459, rs2233678, rs2233679, rs2233682, rs2233683, rs2010457) that were included in the further analysis. SNPs rs4804459, rs2233678, rs2233679 and rs2010457 were in linkage disequilibrium in LOAD, EOAD, FTD and control groups (Figure 1). SNPs rs2233682 and rs2233683 had low minor allele frequency.
###end p 28
###begin p 29
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 0 183 0 183 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pairwise linkage disequilibrium between the six genotyped SNPs in a 14 kb region of <italic>PIN1 </italic>(Haploview 4.1) for combined group (n = 321) of all patients (LOAD, EOAD and FTD) and controls</bold>
###xml 141 149 <span type="species:ncbi:9606">patients</span>
Pairwise linkage disequilibrium between the six genotyped SNPs in a 14 kb region of PIN1 (Haploview 4.1) for combined group (n = 321) of all patients (LOAD, EOAD and FTD) and controls. Numbers inside the squares represent the D' value expressed as a percent. Squares without numbers represent D' values of 1.0, indicative of complete linkage disequilibrium. Darker-shaded squares represent pairs with LOD score for linkage disequilibrium of = 2, light grey squares represent D' = 1 but LOD <2, and white squares represent LOD <2 and D' <1.0.
###end p 29
###begin p 30
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 94 102 <span type="species:ncbi:9606">patients</span>
Genotype and allele frequencies of investigated polymorphisms were similar in LOAD, EOAD, FTD patients in comparison with the controls. Distribution of polymorphisms heterozygous in the studied groups is presented in Table 1. All observed genotype frequencies in the affected and the control group were in the Hardy-Weinberg equilibrium (p > 0.05). The statistical power for comparison of the LOAD (n = 111) and the control (n = 104) groups was sufficient to detect with 80% probability true differences of the allele and haplotype frequencies in the range from 5% (for the most rare alleles) to 12% (for the most common alleles). The respective detectable differences were 6% to 17% for both EOAD (n = 49) and FTD (n = 57) groups when compared to the controls.
###end p 30
###begin p 31
Frequencies of six heterozygous in the Polish population PIN1 polymorphisms
###end p 31
###begin p 32
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE4 </italic>
###xml 126 128 124 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 234 240 232 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE4 </italic>
###xml 60 68 <span type="species:ncbi:9606">patients</span>
###xml 186 194 <span type="species:ncbi:9606">patients</span>
There were significantly more APOE4 carriers among the LOAD patients (63.06%) in comparison to the control group (21.15%) (chi2 = 38.52, df = 1, p < 0.00001). Stratification of the LOAD patients and the control group according to the APOE4 status had no influence on their allele or genotype distribution - there were no significant differences between the groups (p > 0.1, data not shown). In addition, none of the studied polymorphisms affected the age at onset of LOAD symptoms (p > 0.1, data not shown).
###end p 32
###begin p 33
###xml 86 87 86 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
Polymorphisms heterozygous in the studied groups determined 3 major haplotypes (Table 2). Among them, the most frequent one, CGTGCA was present in >64% chromosomes. GGCGCG and CCCGCG had a frequency >17% and >9%, respectively. Other identified haplotypes had minor frequencies (<3%). None of the haplotypes was associated with disease status (Table 2).
###end p 33
###begin p 34
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 51 59 <span type="species:ncbi:9606">patients</span>
Frequency of PIN1 haplotypes in LOAD, EOAD and FTD patients compared with the control group
###end p 34
###begin p 35
* The five haplotype loci correspond to SNPs 1-6 in Figure 1
###end p 35
###begin p 36
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
The number of haplotypes within the 14 kb block was greater than the number of SNPs plus one. However, the excess of haplotypes (11 vs 6+1, respectively, Table 2) was still small, which could suggest relatively few recombination events in the past.
###end p 36
###begin p 37
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 719 724 719 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 756 757 756 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 58 66 <span type="species:ncbi:9606">patients</span>
###xml 562 570 <span type="species:ncbi:9606">patients</span>
###xml 705 713 <span type="species:ncbi:9606">patients</span>
Four novel PIN1 variants were identified in six unrelated patients with familial AD (summarized in Table 3). All of identified variants were nucleotide substitutions absent in the control group. We detected one promoter mutation (g.9805834T>C, GenBank ), localized 1187 bases upstream the translation start codon. In exon 1 a silent substitution was found (c.24C>T, GenBank  and ), changing the third base of codon 8. Two other variants were localized in introns, c.58+64C>T in intron 1 and c.382+105C>T in intron 3. No sequence alterations were detected in the patients with FTD. As PIN1 was postulated to play an important role in oncogenesis, any recognized tumor or cancer in life history of analyzed patients with PIN1 variants was indicated in Table 3.
###end p 37
###begin p 38
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
New sequence variants in PIN1 and brief description of their carriers.
###end p 38
###begin p 39
###xml 294 299 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 520 525 520 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 568 569 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S3">3</xref>
###xml 543 550 <span type="species:ncbi:9606">patient</span>
Unfortunately, out of the six mutation carriers, only one was available for further investigation. The other five individuals died before the conduction of the study. As Fanghanel et al. (2006) suggested, Pin1 activity is mainly controlled by its expression level. Therefore, in order to asses PIN1 expression in the carrier of variant c.58+64C>T, we performed quantitative PCR. Relative quantification, using endogenous control gene, SDHA, and four healthy individuals for data normalization, revealed a 2.82 decreased PIN1 mRNA level in the patient (Additional file 3).
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 435 436 435 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 690 692 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
Several lines of evidence indicate the importance of PIN1 in the nervous system. PIN1 is expressed in different brain regions at least three-fold higher than in other tissues [41] and has been postulated to be involved in neuronal differentiation and in maintaining normal neuronal functions and their postmitotic state [3,4]. Moreover, PIN1 was demonstrated to have a pivotal role in protecting against age-related neurodegeneration [4]. In Alzheimer's disease PIN1 depletion was related to exacerbated tau hyperphosphorylation, generation of NFT and neurotoxic Abeta and subsequent amyloid plaque formation. Additionally, PIN1 depletion was suggested to contribute to neuronal apoptosis [42].
###end p 41
###begin p 42
###xml 154 158 154 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1</italic>
To test the hypothesis that PIN1 dysfunction in AD and/or FTD could be connected with genetic variability, we analyzed the promoter and coding regions of PIN1.
###end p 42
###begin p 43
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 571 579 <span type="species:ncbi:9606">patients</span>
Our data does not support the role of 18 common PIN1 polymorphisms as AD or FTD risk factors. Neither individual alleles, nor haplotypes were associated with EOAD, LOAD or FTD risk. Our findings conflicted with Segat et al. (2007) reports of -842C SNP and -842C/-667C haplotype association with AD in the Northern Italian population, however, they were consistent with the data from the American, French and other Italian cohorts [26-28]. The identified variants g.9805834T>C, c.24C>T and c.382+105C>T are all located on the most prevalent haplotypes, CGTGCA/GGCGCG. The patients with variant c.58+64C>T belonged to diplotypes CGTGCA/CGCGCA, CCCGCG/CGCACA and CCCGTA/CGCACA.
###end p 43
###begin p 44
###xml 366 367 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 111 119 <span type="species:ncbi:9606">patients</span>
We did not identify sequence variants or haplotype associated with the risk for FTD. On one hand enrolling FTD patients without neuropathological characterization could be seen as a weakness of our study, not allowing us to stratify this group according to tau pathology. However, Thorpe et al (2004) identified PIN1 depletion in FTD with and without tau pathology [7].
###end p 44
###begin p 45
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 135 140 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 414 418 414 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1</italic>
###xml 516 521 516 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 69 77 <span type="species:ncbi:9606">patients</span>
Additionally, we identified four novel PIN1 sequence variants in six patients with familial AD (Table 3). One variant was found in the PIN1 promoter region (g.9805834T>C), one in exon 1 (a silent substitution c.24C>T) and two in introns 1 and 3 (c.58+64C>T and c.382+105C>T). None of them was found in the previous studies [26,28]. Variant c.382+105C>T due to its location is rather unlikely to affect splicing of PIN1. The putative role of other variants is described below. All of them could potentially influence PIN1 expression and/or splicing.
###end p 45
###begin title 46
In silico analysis of g.9805834T>C variant
###end title 46
###begin p 47
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In silico </italic>
In silico analysis of the identified g.9805834T>C promoter variant using Matinspector predicted that it could disrupt the binding sites for four transcription factors/transcription factor families: FAST-1 SMAD interacting proteins, PAR/bZIP family, CCAAT/Enhancer Binding Protein (C/EBPs) and Ikaros zinc finger family. Similar analysis performed by another tool, Mapper, confirmed loss of the sites for C/EBPs and PAR/bZIP family, which could be due to similarities between the consensus sequences recognized by both leucine zipper transcription factor families. In both analyses C/EBP binding site obtained higher matrix similarity scores than the PAR/bZIP family.
###end p 47
###begin p 48
###xml 253 255 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 256 258 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 381 383 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 384 386 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
The CCAAT/Enhancer Binding Proteins (C/EBPs) belong to the superfamily of transcription factors, which includes c-Jun, c-Fos and cAMP response element binding protein (CREB). C/EBPbeta is required for neuronal differentiation, maturation and apoptosis [43-45]. Additionally, it plays an important role in the consolidation of mammalian long-term memory and in synaptic plasticity [46,47].
###end p 48
###begin p 49
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 275 280 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 441 443 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 468 473 465 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 690 695 687 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
The activity of C/EBPs depends on the phosphorylation status of their Ser/Thr-Pro motifs and PIN1 was suggested to participate in their post-translational modifications [48]. Mutual interactions of both proteins can affect their common partner, E2F. It was demonstrated that PIN1 expression is mediated by E2F [49] and that C/EBPbeta regulates E2F target gene activation by interacting with E2F and presumably by binding to their promoters [16]. Analysis of the whole PIN1 promoter region revealed one (Mapper) or two (Matinspector) binding sites for C/EBPs in the promoter sequence. Therefore, the loss of C/EBP binding site by g.9805834T>C variant might affect EF2 mediated activation of PIN1 transcription.
###end p 49
###begin title 50
In silico analysis of c.24G>T variant
###end title 50
###begin p 51
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 384 435 384 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pan troglodytes, Canis lupus familiaris, Bos taurus</italic>
###xml 437 460 437 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila melanogaster</italic>
###xml 331 336 <span type="species:ncbi:9606">human</span>
###xml 384 399 <span type="species:ncbi:9598">Pan troglodytes</span>
###xml 401 423 <span type="species:ncbi:9615">Canis lupus familiaris</span>
###xml 425 435 <span type="species:ncbi:9913">Bos taurus</span>
###xml 437 460 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 511 516 <span type="species:ncbi:9606">human</span>
###xml 530 535 <span type="species:ncbi:4932">yeast</span>
c.24G>T is a synonymous substitution (8Pro, CCG>CCT), localized in a region participating in the PIN1 WW domain formation, responsible for binding hyperphosphorylated Tau [5]. ConSeq predicted that 8Pro is a highly conserved residue. In addition, Multiple Sequence Alignment revealed that this position is highly conserved between human PIN1 and its homologs in several species (e.g. Pan troglodytes, Canis lupus familiaris, Bos taurus, Drosophila melanogaster). Moreover, the proline is also conserved between human PIN1 and its yeast ortholog, Ess1p.
###end p 51
###begin p 52
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
Despite c.24G>T variant does not affect protein coding, it might disrupt specific splicing elements. Recently, it has been acknowledged that silent changes have the potential to alter the efficiency and specificity of splicing, and contribute to phenotypic variability [50,51].
###end p 52
###begin p 53
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 528 533 528 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 821 823 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
Analysis of exon 1 sequence by software that detects exonic splicing enhancer (ESE) sites indicated that c.24G>T variant is located within five putative ESE (Table 4). Importantly, using the default settings of ESEfinder, the program predicted that this transversion might disrupt one putative ESE recognized by SF2/ASF, reduce high score of another SF2/ASF motif and enhance binding of SF2/ASF (IgM-BRCA1). ESEfinder anticipated that c.24G>T mutation might shift a putative responsive site for SC35 four nucleotides downstream PIN1 sequence. Moreover, c.24G>T could increase binding of SRp55 and generate SRp40 motif. However, the new putative SRp40 motif (CCTCCCG) would overlap with the recognition site for SF2/ASF (IgM-BRCA1) (CTCCCGG). Simultaneous binding of two overlapping ESEs is considered as rather unlikely [51].
###end p 53
###begin p 54
Effect of c.24G>T mutation on calculated exonic splicing enhancer motifs scores.
###end p 54
###begin p 55
Only motifs distinguishing wild type DNA sequence and the one with mutation c.24G>T, with scores above the thresholds, are presented.
###end p 55
###begin title 56
Analysis of c.58+64C>T variant
###end title 56
###begin p 57
###xml 285 291 285 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE4 </italic>
###xml 386 393 386 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE3/4</italic>
###xml 427 433 427 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE4 </italic>
###xml 467 473 467 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE4 </italic>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 101 109 <span type="species:ncbi:9606">patients</span>
###xml 210 217 <span type="species:ncbi:9606">patient</span>
###xml 319 327 <span type="species:ncbi:9606">patients</span>
Variant c.58+64C>T (according to the GenBank accession numbers  and ) was identified in three female patients, one with familial EOAD (fEOAD) and two with familial LOAD (fLOAD). The earlier age at onset of the patient with EOAD (54 years) could be explained by carrying two alleles of APOE4 in comparison with two LOAD patients (aged 70 and 71 years) with the same variant but genotype APOE3/4. As dose-effect relation data on APOE4 allele suggests, homozygosity for APOE4 might have accelerated the age at onset in carrier of c.58+64C>T variant [52].
###end p 57
###begin p 58
###xml 489 491 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 492 494 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 768 770 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 733 740 <span type="species:ncbi:9031">chicken</span>
Importantly, c.58+64C>T substitution is located in an alternative exon found selectively in testis (The AceView genes: ). An online tool, Automated Splice Site Analysis, revealed that c.58+64C>T substitution increases 14.3 fold the strength of a potential binding site for SC35 situated one nucleotide upstream the variant. Previously, SC35 was reported to be responsible for aberrant splicing of the E1alpha Puryvate Dehydrogenase (PDHA1) mRNA in mental retardation with lactic acidosis [53,54]. Moreover, RegRNA program revealed that the c.58+64C>T substitution introduces two intronic splicing enhancers, an intronic AGGG motif (on + strand) and CTGC (on - strand). (A/U)GGG motif was shown to enhance alternative splicing of the chicken beta-tropomyosin pre-mRNA [55], thus introduction of another (A/U)GGG motif to the three preexisting ones in the 5' part of intron 1 could affect its splicing.
###end p 58
###begin p 59
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 231 232 231 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 26 33 <span type="species:ncbi:9606">patient</span>
###xml 219 227 <span type="species:ncbi:9606">patients</span>
Variant c.58+64C>T in the patient with AAO of 51 years was associated with a 2.82 fold decreased PIN1 expression in the blood leukocytes. As decreased PIN1 level was previously observed in brains of Alzheimer's disease patients [2,7,15], it raises the possibility that identified variant could exert more profound effects in the brain.
###end p 59
###begin p 60
###xml 91 96 91 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 718 723 718 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 593 598 <span type="species:ncbi:9606">human</span>
Presented results concerning c.58+64C>T variant are consistent with the hypothesis linking PIN1 downregulation with amyloidogenic APP processing and aberrant cell cycle re-entry. As it stemmed from the observations of Fanghanel and coworkers (2006), even a basal level of PPIase activity complement a lethal cell cycle dysfunction related to PIN1 dysfunction at the single cell level [56]. However, in organs with high levels of PIN1 activity, like brain and testis, the basal activity is not sufficient to complement the pathology. This observation suggests that decrease in PIN1 activity in human brain could lead to neurodegeneration. The deleterious effect could be mediated either by oxidative stress, or by rare PIN1 sequence variation.
###end p 60
###begin title 61
Conclusion
###end title 61
###begin p 62
###xml 352 357 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 423 428 423 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 601 606 601 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 453 461 <span type="species:ncbi:9606">patients</span>
Despite our data do not directly support the role of common PIN1 polymorphisms as AD risk factor, presented results concerning c.58+64C>T variant could be interpreted as being consistent with the hypothesis linking PIN1 downregulation with amyloidogenic APP processing and aberrant cell cycle re-entry. Presented data of the identification of four new PIN1 sequence variants underscore the importance of further studies on PIN1 variation in familial AD patients. None of the variants was connected with very early onset AD and/or rapid progression of the disease. Therefore, our findings suggest that PIN1 variants could be causally connected with familial AD with age at onset ranging from 45 to 75 years.
###end p 62
###begin title 63
Competing interests
###end title 63
###begin p 64
The authors declare that they have no competing interests.
###end p 64
###begin title 65
Authors' contributions
###end title 65
###begin p 66
###xml 87 97 87 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico </italic>
AM and CZ conceived this study. AM and KS performed statistical analysis. AM performed in silico analysis. AM, KJ, MO, and MB performed described experiments
###end p 66
###begin p 67
KG, BKH, Maria Styczynska, JS, DC, AT, and MB collected blood, mRNA and clinical data.
###end p 67
###begin p 68
AM, CZ, and KS participated in the management, analysis, interpretation of the data and drafting of the manuscript. All authors read and approved the manuscript.
###end p 68
###begin title 69
Pre-publication history
###end title 69
###begin p 70
The pre-publication history for this paper can be accessed here:
###end p 70
###begin p 71

###end p 71
###begin title 72
Supplementary Material
###end title 72
###begin title 73
Additional file 1
###end title 73
###begin p 74
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Supplementary Table 1</bold>
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
Supplementary Table 1. Primers used for PIN1 gene amplification.
###end p 74
###begin p 75
Click here for file
###end p 75
###begin title 76
Additional file 2
###end title 76
###begin p 77
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Supplementary Table 2</bold>
###xml 61 66 61 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
Supplementary Table 2. DHPLC temperature for the analysis of PIN1 gene fragments.
###end p 77
###begin p 78
Click here for file
###end p 78
###begin title 79
Additional file 3
###end title 79
###begin p 80
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Supplementary Table 3</bold>
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIN1 </italic>
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDHA </italic>
Supplementary Table 3. Primers used for real-time PCR for PIN1 and SDHA are shown.
###end p 80
###begin p 81
Click here for file
###end p 81
###begin title 82
Acknowledgements
###end title 82
###begin p 83
This work was supported by the Ministry of Science and Higher Education grants 2 PO5A 171 29 and PBZ-KBN-124/P05/2004.
###end p 83
###begin p 84
A. Maruszak obtained a stipend from Novartis Poland.
###end p 84
###begin article-title 85
PIN1, the cell cycle and cancer
###end article-title 85
###begin article-title 86
Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease
###end article-title 86
###begin article-title 87
Pin1 allows for differential Tau dephosphorylation in neuronal cells
###end article-title 87
###begin article-title 88
Role of the prolyl isomerase PIN1 in protecting against age-dependent neurodegeneration
###end article-title 88
###begin article-title 89
The prolyl isomerase PIN1 restores the function of Alzheimer-associated phosphorylated tau protein
###end article-title 89
###begin article-title 90
Pinning down proline-directed phosphorylation signaling
###end article-title 90
###begin article-title 91
Shortfalls in the peptidyl-prolyl cis-trans isomerase protein PIN1 in neurons are associated with frontotemporal dementias
###end article-title 91
###begin article-title 92
PIN1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies
###end article-title 92
###begin article-title 93
Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2
###end article-title 93
###begin article-title 94
The prolyl isomerase PIN1 regulates amyloid precursor protein processing and amyloid-beta production
###end article-title 94
###begin article-title 95
Tau and GSK3beta dephosphorylations are required for regulating PIN1 phosphorylation
###end article-title 95
###begin article-title 96
PIN1 promoter polymorphisms are associated with Alzheimer's disease
###end article-title 96
###begin article-title 97
Pinning down phosphorylated tau and tauopathies
###end article-title 97
###begin article-title 98
PIN1 promotes production of Alzheimer's amyloid beta from beta-cleaved amyloid precursor protein
###end article-title 98
###begin article-title 99
Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD
###end article-title 99
###begin article-title 100
The significance of Pin1 in the development of Alzheimer's disease
###end article-title 100
###begin article-title 101
PIN1 in Alzheimer's disease: multiple substrates, one regulatory mechanism?
###end article-title 101
###begin article-title 102
Pin1 deregulation in Alzheimer's disease: A role in the aberrant cell cycle re-entry?
###end article-title 102
###begin article-title 103
###xml 0 4 <span type="species:ncbi:10090|species:ncbi:10095">Mice</span>
Mice lacking PIN1 develop normally, but are defective in entering cell cycle from G(0) arrest
###end article-title 103
###begin article-title 104
Association of genome instability and neurodegeneration in the cerebral cortex and hippocampus in Alzheimer's disease brain: Evidences for a new pathogenetic mechanism of the disease
###end article-title 104
###begin article-title 105
Alzheimer's presenilin 1 causes chromosome missegregation and aneuploidy
###end article-title 105
###begin article-title 106
Alzheimer's disease, the two-hit hypothesis: an update
###end article-title 106
###begin article-title 107
Down's syndrome and Alzheimer's disease: two sides of the same coin
###end article-title 107
###begin article-title 108
Oxidative modification and down-regulation of PIN1 in Alzheimer's disease hippocampus: A redox proteomics analysis
###end article-title 108
###begin article-title 109
PIN-1 promoter polymorphisms in mild cognitive impairment and susceptibility to Alzheimer's disease: a preliminary report
###end article-title 109
###begin article-title 110
DNA sequence variations in the prolyl isomerase PIN1 gene and Alzheimer's disease
###end article-title 110
###begin article-title 111
Association study of the PIN1 gene with Alzheimer's disease
###end article-title 111
###begin article-title 112
Association studies between common variants in prolyl isomerase PIN1 and the risk for late-onset Alzheimer's disease
###end article-title 112
###begin article-title 113
Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups
###end article-title 113
###begin article-title 114
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria
###end article-title 114
###begin article-title 115
A simple and efficient method for apolipoprotein E genotype determination
###end article-title 115
###begin article-title 116
Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography
###end article-title 116
###begin article-title 117
The -22c/t polymorphism in presenilin 1 gene is not connected with late-onset and early-onset familial Alzheimer's disease in Poland
###end article-title 117
###begin article-title 118
MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data
###end article-title 118
###begin article-title 119
An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers
###end article-title 119
###begin article-title 120
ESEfinder: a web resource to identify exonic splicing enhancers
###end article-title 120
###begin article-title 121
Automated splicing mutation analysis by information theory
###end article-title 121
###begin article-title 122
###xml 24 29 <span type="species:ncbi:9606">human</span>
Information analysis of human splice site mutations
###end article-title 122
###begin article-title 123
Haploview: analysis and visualization of LD and haplotype maps
###end article-title 123
###begin article-title 124
Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms
###end article-title 124
###begin article-title 125
Neural system-enriched gene expression: relationship to biological pathways and neurological diseases
###end article-title 125
###begin article-title 126
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human peptidyl-prolyl isomerase essential for regulation of mitosis
###end article-title 126
###begin article-title 127
CCAAT/Enhancer-binding Protein beta Plays a Regulatory Role in Differentiation and Apoptosis of Neuroblastoma Cells
###end article-title 127
###begin article-title 128
An essential role for a MEK-C/EBP pathway during growth factor-regulated cortical neurogenesis
###end article-title 128
###begin article-title 129
CCAAT/enhancer-binding protein phosphorylation biases cortical precursors to generate neurons rather than astrocytes in vivo
###end article-title 129
###begin article-title 130
The consolidation of new but not reactivated memory requires hippocampal C/EBPbeta
###end article-title 130
###begin article-title 131
Fornix-dependent induction of hippocampal CCAAT enhancer-binding protein [beta] and [delta] Co-localizes with phosphorylated cAMP response element-binding protein and accompanies long-term memory consolidation
###end article-title 131
###begin article-title 132
Phospho-dependent protein recognition motifs contained in C/EBP family of transcription factors: in silico studies
###end article-title 132
###begin article-title 133
PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells
###end article-title 133
###begin article-title 134
###xml 62 67 <span type="species:ncbi:9606">human</span>
Distribution of SR protein exonic splicing enhancer motifs in human protein-coding genes
###end article-title 134
###begin article-title 135
Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1
###end article-title 135
###begin article-title 136
Genetic heterogeneity of Alzheimer's disease: Complexity and advances
###end article-title 136
###begin article-title 137
The SR protein SC35 is responsible for aberrant splicing of the E1alpha pyruvate dehydrogenase mRNA in a case of mental retardation with lactic acidosis
###end article-title 137
###begin article-title 138
Splicing error in E1alpha pyruvate dehydrogenase mRNA caused by novel intronic mutation responsible for lactic acidosis and mental retardation
###end article-title 138
###begin article-title 139
###xml 82 89 <span type="species:ncbi:9031">chicken</span>
An intronic (A/U)GGG repeat enhances the splicing of an alternative intron of the chicken beta-tropomyosin pre-mRNA
###end article-title 139
###begin article-title 140
###xml 141 145 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Comparative analysis of enzyme activities and mRNA levels of peptidyl prolyl cis/trans isomerases in various organs of wild type and Pin1-/- mice
###end article-title 140

